Australia, Dec. 14 -- Tryptamine Therapeutics Ltd. (TYP) has reported gross short sales of 197,136 FPO shares on Dec. 12. The percent of issued capital of the company reported as short sales is 0.01 percent. The issued capital of the company is 1,226,548,588 shares.
Disclaimer: Curated by HT Syndication.
